1629 related articles for article (PubMed ID: 27444041)
1. Gut microbiota in autoimmunity: potential for clinical applications.
Kim D; Yoo SA; Kim WU
Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
[TBL] [Abstract][Full Text] [Related]
2. Intestinal dysbiosis and probiotic applications in autoimmune diseases.
de Oliveira GLV; Leite AZ; Higuchi BS; Gonzaga MI; Mariano VS
Immunology; 2017 Sep; 152(1):1-12. PubMed ID: 28556916
[TBL] [Abstract][Full Text] [Related]
3. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
Wing AC; Kremenchutzky M
Benef Microbes; 2019 Feb; 10(1):27-32. PubMed ID: 30525949
[TBL] [Abstract][Full Text] [Related]
5. [Intestinal immune response is regulated by gut microbe].
Tanemoto S; Sujino T; Kanai T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):408-415. PubMed ID: 29367525
[TBL] [Abstract][Full Text] [Related]
6. Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases.
Marietta E; Mangalam AK; Taneja V; Murray JA
Front Immunol; 2020; 11():573079. PubMed ID: 33193357
[TBL] [Abstract][Full Text] [Related]
7. The human microbiome in rheumatic autoimmune diseases: A comprehensive review.
Coit P; Sawalha AH
Clin Immunol; 2016 Sep; 170():70-9. PubMed ID: 27493014
[TBL] [Abstract][Full Text] [Related]
8. Intestinal Dysbiosis and Rheumatoid Arthritis: A Link between Gut Microbiota and the Pathogenesis of Rheumatoid Arthritis.
Horta-Baas G; Romero-Figueroa MDS; Montiel-Jarquín AJ; Pizano-Zárate ML; García-Mena J; Ramírez-Durán N
J Immunol Res; 2017; 2017():4835189. PubMed ID: 28948174
[TBL] [Abstract][Full Text] [Related]
9. Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity.
Kinashi Y; Hase K
Front Immunol; 2021; 12():673708. PubMed ID: 33968085
[TBL] [Abstract][Full Text] [Related]
10. Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis.
Czaja AJ
World J Gastroenterol; 2016 Nov; 22(42):9257-9278. PubMed ID: 27895415
[TBL] [Abstract][Full Text] [Related]
11. Role of Microbiome and Antibiotics in Autoimmune Diseases.
Vangoitsenhoven R; Cresci GAM
Nutr Clin Pract; 2020 Jun; 35(3):406-416. PubMed ID: 32319703
[TBL] [Abstract][Full Text] [Related]
12. The microbiome in autoimmune diseases.
De Luca F; Shoenfeld Y
Clin Exp Immunol; 2019 Jan; 195(1):74-85. PubMed ID: 29920643
[TBL] [Abstract][Full Text] [Related]
13. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
14. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
Peterson CT; Sharma V; Elmén L; Peterson SN
Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
[TBL] [Abstract][Full Text] [Related]
15. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
Chen B; Sun L; Zhang X
J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734
[TBL] [Abstract][Full Text] [Related]
16. Microbial modulation of the gut microbiome for treating autoimmune diseases.
Balakrishnan B; Taneja V
Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):985-996. PubMed ID: 30146910
[TBL] [Abstract][Full Text] [Related]
17. Targeting gut microbiota as a possible therapy for diabetes.
He C; Shan Y; Song W
Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
[TBL] [Abstract][Full Text] [Related]
18. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
Babickova J; Gardlik R
World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
20. Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?
Hatton G; Shawcross DL
Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):1-2. PubMed ID: 30791837
[No Abstract] [Full Text] [Related]
[Next] [New Search]